HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 278, Issue 16, 13696-13705, April 18, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: 278/16/13696    most recent M207567200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nowling, T. Articles by Rizzino, A. Search for Related Content PubMed PubMed Citation Articles by Nowling, T. Articles by Rizzino, A. Social Bookmarking                      What's this?

The Co-activator p300 Associates Physically with and Can Mediate the Action of the Distal Enhancer of the FGF-4 Gene^*

Tamara Nowling^§, Cory Bernadt^¶, Lance Johnson^¶, Michelle Desler, and Angie Rizzino^¶

From the  Eppley Institute for Research in Cancer and Allied Diseases and the ^¶ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198

Distal enhancers commonly regulate gene expression. However, the mechanisms of transcriptional mediation by distal enhancers remain largely unknown. To better understand distal enhancer-mediated transcription, we examined the regulation of the FGF-4 gene. The FGF-4 gene is regulated during early development by a powerful distal enhancer located downstream of the promoter in exon 3. Sox-2 and Oct-3 bind to the enhancer and are required for the activation of the FGF-4 gene. Previously, we implicated the co-activator p300 as a mediator of Sox-2/Oct-3 synergistic activation of a heterologous promoter, suggesting that p300 may play a role in mediating enhancer activation of the FGF-4 gene. In this study, we provide both functional and physical evidence that p300 plays an important role in the action of the FGF-4 enhancer. Specifically, we show that E1a, but not a mutant form of E1a that is unable to bind p300, inhibits enhancer activation of the FGF-4 promoter. We also demonstrate that Gal4/p300 fusion proteins can stimulate the FGF-4 promoter when bound to the FGF-4 enhancer. Additionally, we present evidence that p300 mediation of the FGF-4 enhancer requires acetyltransferase activity. Importantly, we also show that Sox-2 and p300 are physically associated with the endogenous FGF-4 enhancer but weakly associated with the endogenous FGF-4 promoter. These results are consistent with a model of transitory interaction between the distal enhancer and the FGF-4 promoter. Our results also suggest that intragenic distal enhancers may use mechanisms that differ from extragenic distal enhancers.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. L. Kopp, B. D. Ormsbee, M. Desler, and A. Rizzino Small Increases in the Level of Sox2 Trigger the Differentiation of Mouse Embryonic Stem Cells Stem Cells, April 1, 2008; 26(4): 903 - 911. [Abstract] [Full Text] [PDF]

				B. Boer, J. Kopp, S. Mallanna, M. Desler, H. Chakravarthy, P. J. Wilder, C. Bernadt, and A. Rizzino Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes Nucleic Acids Res., March 27, 2007; (2007) gkm059v2. [Abstract] [Full Text] [PDF]

				C. E. Pierreux, V. Vanhorenbeeck, P. Jacquemin, F. P. Lemaigre, and G. G. Rousseau The Transcription Factor Hepatocyte Nuclear Factor-6/Onecut-1 Controls the Expression of Its Paralog Onecut-3 in Developing Mouse Endoderm J. Biol. Chem., December 3, 2004; 279(49): 51298 - 51304. [Abstract] [Full Text] [PDF]